Avelas Biosciences Secures $550,000 Series B Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=521564d6-c295-424e-82e3-413d68eaca59
Date
9/10/2014
Company Name
Avelas Biosciences
Mailing Address
11099 N. Torrey Pines Road La Jolla, CA 92037 USA
Company Description
At Avelas Biosciences, our mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients.
Website
http://www.avelasbio.com
Transaction Type
Venture Equity
Transaction Amount
$550,000
Transaction Round
Series B
Proceeds Purposes
The money will help to fund a first-in-man study of its proprietary fluorescent peptide that lights up cancerous cells in real time during breast cancer surgery.
M&A Terms
Venture Investor